Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-06-13 @ 8:10 PM
Study NCT ID:
NCT04502394
Status:
UNKNOWN
Last Update Posted:
2022-08-04
First Post:
2020-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
Sponsor:
Kartos Therapeutics, Inc.
Organization: